AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

K-Pio 15 Tablet

Prescription Icon
Prescription Required

Marketer

Blue Cross Laboratories Ltd

Salt Composition

Pioglitazone (15mg)

Overview K-Pio 15 Tablet

Pioglitazone 15mg tablets manage type 2 diabetes in adults by regulating blood glucose. This helps prevent serious diabetic complications such as vision impairment and kidney disease. This medication can be prescribed alone or in combination with other treatments and may be taken with or without food. Consistent daily dosing at the same time maximizes effectiveness. Dosage adjustments are determined by your physician based on treatment response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision elevates the risk of hyperglycemia and subsequent complications including neuropathy, renal failure, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include headache, sinus inflammation, myalgia, and sore throat. Report persistent or bothersome side effects to your doctor. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any pre-existing heart, thyroid, or endocrine disorders before commencing treatment, as it may not be appropriate. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of K-Pio 15 Tablet

Managing type 2 diabetes

Major Benefits of K-Pio 15 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the K-Pio 15 Tablet whole; do not alter its form by chewing, crushing, or breaking. While it can be taken with or without food, consistent timing is recommended.

Common Side effects of K-Pio 15 Tablet:

  • Headache
  • Sore throat
  • Sinus inflammation
  • Muscle pain

How to use K-Pio 15 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. K-Pio 15 Tablet can be consumed with or without food, though consistent timing is recommended.

How K-Pio 15 Tablet works:

K-Pio 15 tablets help manage diabetes by enhancing the body's response to insulin, thereby regulating blood glucose.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with K-Pio 15 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of K-Pio 15 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCAUTION

K-Pio 15 Tablet requires careful consideration when breastfeeding. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system. Close monitoring of the infant's blood glucose levels is necessary while the mother is taking K-Pio 15 Tablet.

DrivingDrivingSAFE

Driving ability is typically unaffected by K-Pio 15 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use K-Pio 15 Tablet without requiring any alteration to the prescribed dosage.

LiverLiverCAUTION

Patients with liver impairment should use K-Pio 15 Tablets cautiously, potentially requiring dosage modification under medical supervision. K-Pio 15 Tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take K-Pio 15 Tablet :

Omit any missed K-Pio 15 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.

Facts to Know About K-Pio 15 Tablet

LabelValue
Type of Compound Glitazone compound
Potential for Dependence None.
Medication Classification Medication for diabetes
Mechanism of Action PPAR gamma activator (from the thiazolidinedione class)

FAQs on K-Pio 15 Tablet

Weight increase, potentially linked to dosage, is a frequent side effect of K-Pio 15 Tablet. This weight gain may result from increased body fat; however, in individuals with heart failure, fluid retention may be the contributing factor. Consequently, close monitoring of weight is crucial for patients with heart failure.
K-Pio 15 Tablet may lead to fluid buildup, potentially worsening or accelerating existing heart failure. For individuals with a pre-existing heart failure risk factor (such as prior myocardial infarction, coronary artery disease, or advanced age), physicians typically initiate therapy with the minimum effective dose, gradually increasing it as needed. Concomitant use of K-Pio 15 Tablet and insulin elevates the likelihood of heart failure.
K-Pio 15 Tablet is an appropriate adjunct to metformin for adult patients with type 2 diabetes mellitus whose blood glucose levels remain inadequately controlled by metformin monotherapy. This dual medication approach is also suitable for overweight individuals exhibiting suboptimal glycemic control.
This medication is typically administered once daily; the specific time of day is flexible, though consistency is recommended. Food is not a requirement for ingestion. Always adhere precisely to your physician's instructions regarding K-Pio 15 Tablet dosage.
Follow your physician's instructions regarding the duration of K-Pio 15 Tablet use. Diabetes mellitus management often requires lifelong medication; discontinuation should only occur after consultation with your doctor, who can provide an appropriate substitute. Ceasing treatment without medical supervision may lead to dangerous elevations in blood glucose levels.
Elevated liver enzyme levels are a potential side effect of K-Pio 15 Tablet; treatment should cease if this occurs. Regular monitoring of liver enzyme levels is therefore necessary during treatment. Patients with pre-existing liver conditions should not receive K-Pio 15 Tablet.
K-Pio 15 tablets are classified as thiazolidinedione antidiabetic agents. Their mechanism of action involves enhancing the body's utilization of insulin, thereby regulating blood glucose concentrations. This effect is achieved by increasing cellular responsiveness to endogenous insulin.
The medication K-Pio 15 Tablet carries a very low, but increased, risk of bladder cancer. Seek immediate medical attention if you develop hematuria, dysuria, or urinary urgency while taking this drug. Patients with a history of bladder cancer should not use K-Pio 15 Tablet.
K-Pio 15 Tablet
29
MRP 35
17% off